Cargando…

Retrospective record review of pregnant women treated for rifampicin-resistant tuberculosis in South Africa

BACKGROUND: Tuberculosis (TB) is amongst the top five causes of death in women of childbearing age (15-≤44 years). Little is known about treatment of pregnant women with drug-resistant TB (DR-TB). Treatment for pregnant women remains challenging and more complex in DR-TB/HIV co-infection, where an e...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Walt, Martie, Masuku, Sikhethiwe, Botha, Sonja, Nkwenika, Tshifhiwa, Keddy, Karen H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7514075/ https://www.ncbi.nlm.nih.gov/pubmed/32970722 http://dx.doi.org/10.1371/journal.pone.0239018

Ejemplares similares

Adherence to Concurrent Tuberculosis Treatment and Antiretroviral Treatment among Co-Infected Persons in South Africa, 2008–2010
por: Webb Mazinyo, Ernesha, et al.
Publicado: (2016)

The Tuberculosis-Depression Syndemic and Evolution of Pharmaceutical Therapeutics: From Ancient Times to the Future
por: Van Der Walt, Martie, et al.
Publicado: (2021)

Developing health policies in patients presenting with SARS-CoV-2: consider tuberculosis
por: Keddy, Karen H, et al.
Publicado: (2020)

Maternal and Infant Outcomes Among Pregnant Women Treated for Multidrug/Rifampicin-Resistant Tuberculosis in South Africa
por: Loveday, Marian, et al.
Publicado: (2020)

Tuberculosis Case Fatality and Other Causes of Death among Multidrug-Resistant Tuberculosis Patients in a High HIV Prevalence Setting, 2000-2008, South Africa
por: van der Walt, Martie, et al.
Publicado: (2016)

The epidemiology of tuberculosis in health care workers in South Africa: a systematic review
por: Grobler, Liesl, et al.
Publicado: (2016)

Treatment Outcomes for Patients with Extensively Drug-Resistant Tuberculosis, KwaZulu-Natal and Eastern Cape Provinces, South Africa
por: Kvasnovsky, Charlotte L., et al.
Publicado: (2016)

Impact of community tracer teams on treatment outcomes among tuberculosis patients in South Africa
por: Bronner, Liza E, et al.
Publicado: (2012)

Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa
por: Mohr, Erika, et al.
Publicado: (2018)

Patient- and provider-level risk factors associated with default from tuberculosis treatment, South Africa, 2002: a case-control study
por: Finlay, Alyssa, et al.
Publicado: (2012)

The relationship between physical fitness and community participation in people with spinal cord injury
por: van der Westhuizen, Linda, et al.
Publicado: (2017)

Tuberculosis among health care workers in KwaZulu-Natal, South Africa: a retrospective cohort analysis
por: Tudor, Carrie, et al.
Publicado: (2014)

Switching to bedaquiline for treatment of rifampicin-resistant tuberculosis in South Africa: A retrospective cohort analysis
por: Bouton, Tara C., et al.
Publicado: (2019)

Effect of a ward-based outreach team and adherence game on retention and viral load suppression
por: Ngcobo, Sanele, et al.
Publicado: (2022)

Coadministration of Lopinavir/Ritonavir and Rifampicin in HIV and Tuberculosis Co-Infected Adults in South Africa
por: Murphy, Richard A., et al.
Publicado: (2012)

Isoniazid and Rifampicin Resistance-Conferring Mutations in Mycobacterium tuberculosis Isolates from South Africa
por: Traoré, Afsatou Ndama, et al.
Publicado: (2023)

Evaluation of a nurse practitioner-physician task-sharing model for multidrug-resistant tuberculosis in South Africa
por: Farley, Jason E., et al.
Publicado: (2017)

Time to ART Initiation among Patients Treated for Rifampicin-Resistant Tuberculosis in Khayelitsha, South Africa: Impact on Mortality and Treatment Success
por: Daniels, Johnny Flippie, et al.
Publicado: (2015)

Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South Africa
por: Salaam-Dreyer, Zubeida, et al.
Publicado: (2021)

Correction: Coadministration of Lopinavir/Ritonavir and Rifampicin in HIV and Tuberculosis Co-Infected Adults in South Africa
por: Murphy, Richard A., et al.
Publicado: (2013)

Development and Evaluation of a Pilot Nurse Case Management Model to Address Multidrug-Resistant Tuberculosis (MDR-TB) and HIV in South Africa
por: Farley, Jason E., et al.
Publicado: (2014)

A Spatial Analysis of COVID-19 in African Countries: Evaluating the Effects of Socio-Economic Vulnerabilities and Neighbouring
por: Manda, Samuel O. M., et al.
Publicado: (2021)

Early Outcomes Of Decentralized Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa: An Observational Cohort Study
por: Berhanu, Rebecca, et al.
Publicado: (2016)

Fluoroquinolone-Resistant Typhoid, South Africa
por: Keddy, Karen H., et al.
Publicado: (2010)

Cost per patient of treatment for rifampicin‐resistant tuberculosis in a community‐based programme in Khayelitsha, South Africa
por: Cox, Helen, et al.
Publicado: (2015)

Injectable-free regimens containing bedaquiline, delamanid, or both for adolescents with rifampicin-resistant tuberculosis in Khayelitsha, South Africa
por: Mohr-Holland, Erika, et al.
Publicado: (2020)

“Take the treatment and be brave”: Care experiences of pregnant women with rifampicin-resistant tuberculosis
por: Loveday, Marian, et al.
Publicado: (2020)

TB tracer teams in South Africa: knowledge, practices and challenges of tracing TB patients to improve adherence
por: Bristow, Claire C, et al.
Publicado: (2013)

Impact of Decentralized Care and the Xpert MTB/RIF Test on Rifampicin-Resistant Tuberculosis Treatment Initiation in Khayelitsha, South Africa
por: Cox, Helen S., et al.
Publicado: (2015)

“A very humiliating illness”: a qualitative study of patient-centered Care for Rifampicin-Resistant Tuberculosis in South Africa
por: Furin, Jennifer, et al.
Publicado: (2020)

Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis
por: Zhang, Zehua, et al.
Publicado: (2014)

Application of the Multistate Tuberculosis Pharmacometric Model in Patients With Rifampicin‐Treated Pulmonary Tuberculosis
por: Svensson, RJ, et al.
Publicado: (2016)

Implementing a Substance-Use Screening and Intervention Program for People Living with Rifampicin-Resistant Tuberculosis: Pragmatic Experience from Khayelitsha, South Africa
por: Reuter, Anja, et al.
Publicado: (2022)

Assessing Local Risk of Rifampicin-Resistant Tuberculosis in KwaZulu-Natal, South Africa Using Lot Quality Assurance Sampling
por: Heidebrecht, Christine L., et al.
Publicado: (2016)

The genomic epidemiology of shigellosis in South Africa
por: Stenhouse, George E., et al.
Publicado: (2023)

Airway microecology in rifampicin-resistant and rifampicin-sensitive pulmonary tuberculosis patients
por: Cai, Xingshan, et al.
Publicado: (2022)

Effect of compensatory evolution in the emergence and transmission of rifampicin-resistant Mycobacterium tuberculosis in Cape Town, South Africa: a genomic epidemiology study
por: Goig, Galo A, et al.
Publicado: (2023)

Quality assurance of rifampicin-containing fixed-drug combinations in South Africa: dosing implications
por: Court, R., et al.
Publicado: (2018)

Prevalence of bacteriologically confirmed pulmonary tuberculosis in South Africa, 2017–19: a multistage, cluster-based, cross-sectional survey
por: Moyo, Sizulu, et al.
Publicado: (2022)

Typhoid Fever in South Africa in an Endemic HIV Setting
por: Keddy, Karen H., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_17rregpnb2e0e06npoi0eiub0d